D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 9.69% |
| 2 | Consumer Discretionary | 9.53% |
| 3 | Technology | 9.28% |
| 4 | Healthcare | 8.29% |
| 5 | Financials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Amdocs
DOX
$5.53B
| $34.8M | 0.05% |
639,120
-50,975
| -7% | -$2.57M |
|
|
POT
402
DELISTED
Potash Corp Of Saskatchewan
POT
| $34.7M | 0.05% |
1,077,440
+1,038,135
| +2,641% | +$36.5M |
|
403
Cirrus Logic
CRUS
$6.74B
| $34.7M | 0.05% |
1,044,656
+757,737
| +264% | +$22M |
|
404
Wynn Resorts
WYNN
$10.1B
| $34.7M | 0.05% |
275,424
-159,173
| -37% | -$22.7M |
|
405
PUT
Home Depot
HD
$332B
| $34.7M | 0.05% |
305,100
-435,300
| -59% | -$48M |
|
406
PUT
Regeneron Pharmaceuticals
REGN
$68.8B
| $34.6M | 0.05% |
76,700
-105,000
| -58% | -$44.5M |
|
407
Expedia Group
EXPE
$31.2B
| $34.5M | 0.05% |
366,989
-637,919
| -63% | -$56.6M |
|
|
FDO
408
DELISTED
FAMILY DOLLAR STORES
FDO
| $34.5M | 0.05% |
435,363
-614,917
| -59% | -$48M |
|
|
ABMD
409
DELISTED
Abiomed Inc
ABMD
| $34.5M | 0.05% |
481,451
+131,113
| +37% | +$7.12M |
|
410
PUT
McKesson
MCK
$98.5B
| $34.4M | 0.05% |
152,200
-320,000
| -68% | -$71M |
|
|
WBA
411
DELISTED
Walgreens Boots Alliance
WBA
| $34.4M | 0.05% |
406,523
-17,346
| -4% | -$1.38M |
|
412
PUT
American Express
AXP
$223B
| $34.2M | 0.05% |
438,300
-36,500
| -8% | -$3.03M |
|
413
CALL
Gilead Sciences
GILD
$161B
| $34.1M | 0.05% |
347,100
-442,000
| -56% | -$44.9M |
|
414
PUT
Goldman Sachs
GS
$313B
| $33.8M | 0.05% |
179,900
-519,100
| -74% | -$96.6M |
|
|
NFX
415
DELISTED
Newfield Exploration
NFX
| $33.7M | 0.05% |
960,474
+168,805
| +21% | +$5.11M |
|
|
BMS
416
DELISTED
Bemis
BMS
| $33.6M | 0.05% |
725,925
+172,309
| +31% | +$8M |
|
|
VIAB
417
DELISTED
Viacom Inc. Class B
VIAB
| $33.3M | 0.05% |
488,171
-516,949
| -51% | -$35.7M |
|
418
PUT
United Parcel Service
UPS
$97.6B
| $33.2M | 0.05% |
342,800
-443,000
| -56% | -$45.5M |
|
|
CST
419
DELISTED
CST Brands, Inc.
CST
| $33.1M | 0.05% |
754,848
+144,488
| +24% | +$6.27M |
|
|
CPN
420
DELISTED
Calpine Corporation
CPN
| $33M | 0.05% |
1,445,154
-251,569
| -15% | -$5.42M |
|
421
Corning
GLW
$126B
| $33M | 0.05% |
1,455,399
+496,608
| +52% | +$11.8M |
|
422
IQVIA
IQV
$34.7B
| $32.6M | 0.05% |
486,847
+321,499
| +194% | +$20.3M |
|
|
VISN
423
Vistance Networks Inc
VISN
$2.66B
| $32.5M | 0.05% |
1,138,148
+775,206
| +214% | +$21.6M |
|
424
Goodyear
GT
$2.07B
| $32.5M | 0.05% |
1,198,983
+567,190
| +90% | +$14.8M |
|
425
Leidos
LDOS
$14.1B
| $32.4M | 0.05% |
771,134
-189,249
| -20% | -$8.23M |
|
Similar funds
D.E. Shaw & Co's Q1 2015 Portfolio in Review
As of Q1 2015, D.E. Shaw & Co held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 9.7% of assets, up from 8% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, D.E. Shaw & Co opened a new position in SPDR Gold Trust worth $231M.
- D.E. Shaw & Co's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- D.E. Shaw & Co's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- D.E. Shaw & Co fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- D.E. Shaw & Co opened 448 new positions and closed 828 in Q1 2015.
- D.E. Shaw & Co's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.